|
HY-100672B-10mg
|
MedChemexpress LLC
|
(2R)-SR59230A [CAS 1932675-95-0]
|
|
|
|
|
HY-100672B-100mg
|
MedChemexpress LLC
|
(2R)-SR59230A [CAS 1932675-95-0]
|
|
|
|
|
HY-100672B-5mg
|
MedChemexpress LLC
|
(2R)-SR59230A [CAS 1932675-95-0]
|
|
|
|
|
HY-100672B-50mg
|
MedChemexpress LLC
|
(2R)-SR59230A [CAS 1932675-95-0]
|
|
|
|
|
HY-100729-10mg
|
MedChemexpress LLC
|
GSK9311 [CAS 1923851-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100729-100mg
|
MedChemexpress LLC
|
GSK9311 [CAS 1923851-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100729-25mg
|
MedChemexpress LLC
|
GSK9311 [CAS 1923851-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100729-5mg
|
MedChemexpress LLC
|
GSK9311 [CAS 1923851-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100729-50mg
|
MedChemexpress LLC
|
GSK9311 [CAS 1923851-49-3]
|
|
Cancer-programmed cell death
|
|
|
HY-100825-1mg
|
MedChemexpress LLC
|
OABK (hydrochloride) [CAS 1984862-48-7]
|
|
|
|
|
HY-100825-10mg
|
MedChemexpress LLC
|
OABK (hydrochloride) [CAS 1984862-48-7]
|
|
|
|
|
HY-100825-100mg
|
MedChemexpress LLC
|
OABK (hydrochloride) [CAS 1984862-48-7]
|
|
|
|
|
HY-100825-5mg
|
MedChemexpress LLC
|
OABK (hydrochloride) [CAS 1984862-48-7]
|
|
|
|
|
HY-100825-50mg
|
MedChemexpress LLC
|
OABK (hydrochloride) [CAS 1984862-48-7]
|
|
|
|
|
HY-100877-1mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-10mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-100mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-25mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-5mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-100877-50mg
|
MedChemexpress LLC
|
GCN2-IN-1 [CAS 1448693-69-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-101027A-10mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101027A-100mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101027A-25mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101027A-5mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
|
HY-101027A-50mg
|
MedChemexpress LLC
|
GSK4028 [CAS 2079886-19-2]
|
|
Cancer-programmed cell death
|
|
